Skip to main content
Covalon Technologies Ltd. logo

Covalon Technologies Ltd. — Investor Relations & Filings

Ticker · COV ISIN · CA22282D3022 TSXV Manufacturing
Open in API
Filings indexed 152 across all filing types
Latest filing 2026-04-15 Regulatory Filings
Country CA Canada
Listing TSXV COV

About Covalon Technologies Ltd.

https://covalon.com/

Covalon Technologies Ltd. researches, develops, manufactures, and commercializes innovative medical devices and healthcare technologies. The company specializes in three core areas: infection management, advanced wound care, and vascular access. Covalon's portfolio includes advanced silicone dressings, specialized coatings, and surgical consumables designed to prevent, detect, and manage medical conditions. Utilizing patented, breakthrough technologies, Covalon aims to transform patient care by prioritizing healing, comfort, and safety, particularly in clinical settings requiring robust infection control and tissue repair solutions.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press/news release about product milestones, conference participation, and forward-looking statements. It does not provide financial results, regulatory filings, board or management changes, share transactions, or governance materials. It is promotional content and does not fit any specific category such as earnings release, investor presentation, or M&A. Therefore it falls under the general fallback category for miscellaneous regulatory announcements.
2026-04-15 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate news release announcing Covalon’s presence and product showcases at a healthcare conference, not financial results, management changes, or any structured regulatory filing listed in other categories. It does not present earnings, annual or interim report content, capital or share transactions, or voting outcomes. Therefore, it falls into the fallback category for miscellaneous announcements (general regulatory/news releases).
2026-04-10 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release (Business Wire) announcing a product showcase at an upcoming medical conference, with marketing and forward-looking statements. It is not an AGM presentation, regulatory financial report, earnings release, management discussion, or any of the other highly specified filings. It does not contain voting results, director changes, M&A, financing updates, dividends, or detailed financial tables. It instead serves as a general corporate news announcement and thus falls into the miscellaneous “Regulatory Filings” fallback category (RNS).
2026-04-10 English
Notice of the meeting and record date - English.pdf
AGM Information Classification · 1% confidence The document is a formal notice from TSX Trust Company regarding the upcoming Annual and Special Meeting of Security Holders for Covalon Technologies Ltd. It specifies record dates, meeting dates, and proxy-related material distribution details. This type of document is a standard regulatory notification sent to exchanges to announce the logistics of an upcoming shareholder meeting, which falls under the category of Proxy Solicitation & Information Statement (PSI) as it relates to the preparation and solicitation process for a shareholder meeting.
2026-01-12 English
News release - English.pdf
Notice of Dividend Amount Classification · 1% confidence The document is a news release from Covalon Technologies Ltd. announcing the payment of its first-ever dividend. It specifies the dividend amount (C$0.15 per share), the payment date (November 18, 2025), and the record date (November 4, 2025). This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2025-11-19 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a Business Wire news release announcing Covalon’s participation in a scientific meeting and detailing product information and contact details. It contains no financial results, regulatory form references, dividend details, or managerial changes. It is not an investor presentation, earnings release, or formal regulatory filing. It does not fit any specific category beyond a general corporate announcement. Therefore, it should be classified in the fallback category: Regulatory Filings (RNS).
2025-09-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.